Bionano Genomics, Inc.

BNGO ·Technology, Scientific & Technical Instruments, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $1.0M
Accounts Receivable $3.4M
Inventory $1.7M
Total Current Assets $7.1M
Property, Plant & Equipment $3.0M
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $10.1M
Liabilities
Accounts Payable $2.3M
Total Current Liabilities $16.7M
Long-Term Debt $0
Total Liabilities $17.4M
Stockholders' Equity
Retained Earnings $-54.3M
Total Stockholders' Equity $-50.2M
← Newer Page 2 of 2 Older →